GlaxoSmithKline (GSK) Reports Q4 EPS of 24.8p
Get Alerts GSK Hot Sheet
Join SI Premium – FREE
(Updated)
GlaxoSmithKline (NYSE: GSK) reported Q4 EPS of 24.80p, better than the analyst estimate of 24.50p. Revenue for the quarter came in at GBP8.9 billion versus the consensus estimate of GBP9.02 billion.
2020 guidance
- Expect Adjusted EPS to decline -1% to -4% CER
- Expect 80p dividend for 2020
For earnings history and earnings-related data on GlaxoSmithKline (GSK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Equifax (EFX) shares tumble on weak Q1 revenue, guidance miss
- SL Green Realty (SLG) Misses Q1 EPS by 8c, provides guidance
- F.N.B. Corp (FNB) Reports In-Line Q1 EPS
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!